Majority
Vol 9 No 1 (2020): MAJORITY

Dampak Infeksi SARS-Cov-2 Terhadap Penderita Hipertensi

Haekal Alfhad (Unknown)
Fitria Saftarina (Unknown)
Betta Kurniawan (Unknown)



Article Info

Publish Date
02 Mar 2022

Abstract

Coronavirus disease 2019 (COVID-19) is the first viral outbreak pneumonia in Wuhan, China, in December 2019, caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-Cov-2). WHO reported 2.241.359 positive cases of COVID-19 patients worldwide, with a cumulative death toll of 152.551 men by April 19, 2020. As in 18 April 2020, Indonesia itself hit 6.248 positive cases with a total of 535 deaths, according to the Indonesian Health Ministry. SARS-Cov-2 is a coronaviral (β) beta group virus. In order to enter the target cell, SARS-CoV 2 uses the ACE Angiotensin conversion enzyme (ACE) 2. This can reduce the function of ACE2 which changes Angiotensin 2 into Angiotensin (1-7). The disrupted production of Angiotensin (1-7) can cause a vasodilator effect that is not optimal, so the condition of people with hypertension can be worsen. The risk of SARS-Cov-2 infection is higher among those suffering from hypertension with the drug Renin-Angiotensin-Aldosterone System inhibitor, due to the expression of ACE2. Overexpression of ACE2 may make it easier for SARS-CoV-2 to penetrate the body.

Copyrights © 2020






Journal Info

Abbrev

majority

Publisher

Subject

Education Health Professions Medicine & Pharmacology Public Health

Description

Jurnal Majority dalah peer-reviewed journal yang mempublikasikan artikel-artikel ilmiah bagi mahasiswa fakultas kedokteran, dosen maupun klinisi. Jurnal Majority menerima manuskrip atau artikel dalam bidang dalam lingkup bidang kedokteran dan kesehatan. Artikel-artikel yang dipublikasikan di Jurnal ...